Rachel Goldstein

Effect of Enzyme-Inducing Antiseizure Medications on the Risk of Sub-Therapeutic Concentrations of Direct Oral Anticoagulants: A Retrospective Cohort Study

D. Singer, M. Muszkat, Y. Kalish, 2021, CNS Drugs.

Patients treated with anti-CD20 therapy can mount robust T cell responses to mRNA-based COVID-19 vaccines

A. Sette, C. Siegrist, A. Grifoni, 2021, medRxiv.

Interactions Between Direct Oral Anticoagulants (DOACs) and Antiseizure Medications: Potential Implications on DOAC Treatment

N. Gronich, M. Bialer, M. Muszkat, 2023, CNS Drugs.

Ischemic and Thrombotic Events Associated with Concomitant Xa-inhibiting Direct Oral Anticoagulants and Antiepileptic Drugs: Analysis of the FDA Adverse Event Reporting System (FAERS)

D. Singer, M. Muszkat, A. Perlman, 2019, CNS Drugs.

Estimation of HIV prevalence and burden in Nigeria: a Bayesian predictive modelling study

A. Onovo, Otse Ogorry, Rachel Goldstein, 2023, EClinicalMedicine.